During the past decade, Peoria Gynecologic Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Peoria Gynecologic Oncology" are "Recurrent Ovarian Epithelial Cancer" (2 trials), "Fallopian Tube Cancer" (1 trials), "Female Reproductive Cancer" (1 trials), "Ovarian Carcinosarcoma" (1 trials) and "Ovarian Sarcoma" (1 trials). Many other conditions were trialed in "Peoria Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "Peoria Gynecologic Oncology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cediranib maleate" (1 trials), "laboratory biomarker analysis" (1 trials) and "ziv-aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peoria Gynecologic Oncology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Peoria Gynecologic Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Peoria Gynecologic Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peoria Gynecologic Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".